SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

72,529.07 -242.65
( -0.33%)

Global Indices

Nasdaq

51,369.65 -132.86
(-0.26%)

Dow Jones

7,690.99 -13.70
(-0.18%)

Hang Seng

65,155.57 -722.05
(-1.10%)

Nikkei 225

10,628.22 -56.66
(-0.53%)

Forex

USD-INR

95.79 -0.10
(-0.10%)

EUR-INR

109.09 0.01
(0.01%)

GBP-INR

126.83 0.01
(0.01%)

JPY-INR

0.61 0.00
(0.68%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Genesys International Corporation Ltd

Industry : Computers - Software - Medium / Small

BSE Code

ISIN Demat

Book Value()

506109

INE727B01026

130.8364017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

GENESYS

101.68

1862.85

EPS(TTM)

Face Value()

Div & Yield %

2.74

Back

venky`s (india) ltd

Shree Ganesh Biotech India reports standalone net loss of Rs 0.57 crore in the June 2026 quarter

Aug 05,2026

Net loss of Shree Ganesh Biotech India reported to Rs 0.57 crore in the quarter ended June 2026 as against net profit of Rs 0.33 crore during the previous quarter ended June 2025. Sales rose 3.62% to Rs 1.43 crore in the quarter ended June 2026 as against Rs 1.38 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1.43	1.38	4
OPM %	-62.24	-6.52	-
PBDT	-0.57	0.33	PL
PBT	-0.57	0.33	PL
NP	-0.57	0.33	PL

72,529.07 -242.65 ( -0.33%)

51,369.65 -132.86 (-0.26%)

7,690.99 -13.70 (-0.18%)

65,155.57 -722.05 (-1.10%)

10,628.22 -56.66 (-0.53%)

95.79 -0.10 (-0.10%)

109.09 0.01 (0.01%)

126.83 0.01 (0.01%)

0.61 0.00 (0.68%)